Clinical Trials on Diabetes, Gestational in Belgium

Total 349 results

University Hospital, Ghent
University Ghent

Recruiting

24-hour Movement Behaviors in Adults With Type 1 Diabetes (24h-MBs_T1D)

Diabetes Mellitus, Type 1

Belgium
Canterbury Christ Church University
Kinetic Analysis; Medway Community Healthcare; Blackthorn Trust; Arteveldehoges... and other collaborators

Completed

Evaluation of Diabetes and WELLbeing Programme (DWELL)

Type 2 Diabetes | Type 2 Diabetes Treated With Insulin

Belgium, France, Netherlands, United Kingdom
Boehringer Ingelheim

Completed

This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses)

Diabetic Nephropathies

United States, Canada, Belgium, Czechia, Germany
India Diabetes Research Foundation & Dr. A. Ramachandran...

Completed

A Study on Comparison of Glargine Plus Glulisine With Premixed Insulin in Type 2 Diabetes Patients

Type2 Diabetes

India
Sahlgrenska University Hospital, Sweden
Karolinska Institutet; Imperial College London; University Hospital, Ghent; Universitair... and other collaborators

Completed

Early Glycaemic Control in Type 2 Diabetes Patients After Bariatric Surgery; ECODABS

Diabetes Mellitus Type 2 in Obese

Spain, Sweden, Belgium, United Kingdom
GlaxoSmithKline

Completed

Subcutaneous Administration of Otelixizumab to T1DM Patients (RAO112438)

Diabetes Mellitus, Type 1

Belgium
AZ-VUB
KU Leuven; Universiteit Antwerpen; Erasme University Hospital

Completed

Extension of Phase II Therapeutic Trial With a Humanized Non-Mitogenic CD3 (ChAgly CD3) Monoclonal Antibody in Recently Diagnosed Type 1 Diabetic Patients

Diabetes Mellitus, Type 1

Belgium, Germany
Centre d'Etudes et de Recherche pour l'Intensification...

Completed

Diabeloop for Kids (DBL4K)

Diabetes Mellitus, Type 1 | Closed Loop | Young Children (6 to 12 Years Old )

Belgium, France
Universitaire Ziekenhuizen KU Leuven
University Hospital, Ghent; Universitair Ziekenhuis Brussel; University Hospital... and other collaborators

Completed

Closed-loop Insulin Delivery in Pregnant Women With Type 1 Diabetes (CRISTAL)

Type1 Diabetes

Belgium, Netherlands
Université Catholique de Louvain

Completed

Hyperglycaemia In Childhood Hematologic Malignancies (DIAB-ONCO)

Diabetes Mellitus Risk

Belgium
Dompé Farmaceutici S.p.A

Completed

A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study in Patients With New-onset Type 1 Diabetes

Diabetes Mellitus, Insulin-Dependent

Germany, Belgium, Italy
Oxurion

Completed

A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME)

Diabetes Mellitus | Diabetic Retinopathy | Macular Edema

France, United Kingdom, Belgium, Spain, Germany, Slovakia, Switzerland
Biocon Limited

Terminated

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients

Type 1 Diabetes Mellitus

India
University Hospital, Antwerp
Becton, Dickinson and Company

Completed

Lipohypertrophy Monitoring Study (LiMo)

Diabetes Mellitus | Hypoglycemia | Lipohypertrophy

Belgium
Becton, Dickinson and Company

Terminated

An Audit of the Impact of Tailored Information Delivered Via a Digital Learning Platform

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Belgium
Centre d'Etudes et de Recherche pour l'Intensification...

Recruiting

Diabeloop For Teens (DBL4T)

Diabetes Mellitus, Type 1 | Closed Loop | Adolescents (12 to 17 Years Old)

Belgium, France, Germany
Erasme University Hospital

Enrolling by invitation

Insulin Delivery Using the DBLG1 Closed-loop on Glycemic Control and PROMs in Adults Living With Type 1 Diabetes (INLOOP)

Diabetes Mellitus, Type 1

Belgium
Christophe De Block

Unknown

Diabetes Mellitus After Intensive Care Admission (DIAFIC)

Diabetes Mellitus | Stress Hyperglycemia

Belgium
Eli Lilly and Company

Completed

Treatment of Peripheral Neuropathy in Patients With Diabetes

Diabetes Mellitus | Diabetic Neuropathies

United States, Spain, Australia, Belgium, Canada, Croatia, Denmark, Estonia, Finland, Germany, Hungary, India, Lithuania, Netherlands, United Kingdom
GlaxoSmithKline
Parexel

Completed

Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients

Diabetes Mellitus, Type 1

Belgium
Technical University of Munich
Universitaire Ziekenhuizen KU Leuven; Helmholtz Zentrum München; Medical University... and other collaborators

Active, not recruiting

GPPAD-POInT (Global Platform of Autoimmune Diabetes - Primary Oral Insulin Trial)

Diabetes Mellitus, Type 1

Belgium, Germany, Poland, Sweden, United Kingdom
Pfizer

Completed

The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (A6301086)

Diabetic Foot Ulcer

Canada, Austria, Czech Republic, Sweden, Russian Federation, Poland, Norway, United Kingdom, Italy, Belgium, Denmark, Germany, Greece, Ukraine
Sanofi

Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)

Type 2 Diabetes Mellitus

India
Centre Hospitalier Universitaire Saint Pierre
AstraZeneca

Terminated

Effect of the Antidiabetic Drug Dapagliflozin on the Coronary Macrovascular and Microvascular Function in Type 2 Diabetic Patients (DAPAMICRO)

Diabetes Mellitus, Type 2

Belgium
UCB Pharma

Completed

Study Evaluating Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy.

Painful Diabetic Neuropathy

Russian Federation, Austria, Belgium, Bulgaria, Czechia, Finland, France, Germany, Hungary, Italy, Poland, Romania, Serbia, Spain, United Kingdom
Novartis Pharmaceuticals

Terminated

Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN) (EMPADINE)

Painful Diabetic Neuropathy

Belgium, Austria, Germany, Australia, United Kingdom, Bulgaria, Slovakia, Hungary, Spain, Portugal, France, Poland, Denmark, Norway, Canada, Finland
Astellas Pharma Inc

Completed

A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients (PACE)

Painful Diabetic Peripheral Neuropathy (PDPN)

Belgium, Czech Republic, France, Germany, Italy, Netherlands, Poland, Russian Federation, Spain, Ukraine, United Kingdom
Jessa Hospital
Wit-Gele Kruis Limburg; KLAV; Ferm Thuiszorg; I-mens; Vlaams Patiëntenplatform; Wit-Gele... and other collaborators

Recruiting

Visualisation of a Digital Care Pathway.

Type 2 Diabetes | Patient Empowerment | Patient Acceptance of Health Care | Multidisciplinary Communication | Empowerment

Belgium
Olympus Biotech Corporation

Completed

The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study (TRANS-North)

Diabetic Foot Ulcer of Neuropathic Origin

Belgium, Germany, Poland, Croatia, Bulgaria, Denmark, Slovakia, Hungary, Netherlands, Sweden
ChemoCentryx

Completed

A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy

Type 2 Diabetes Mellitus | Diabetic Nephropathy

Poland, United Kingdom, Germany, Belgium, Hungary, Czechia
Centre d'Etudes et de Recherche pour l'Intensification...

Completed

Validation of a Predictive Risk Equation for Type 2 Diabetes in Families With Risk (DESCENDANCE)

Type 2 Diabetes

France, Belgium
Fractyl Health Inc.

Completed

Evaluation of Duodenal Mucosal Resurfacing in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes Mellitus

United Kingdom, Belgium, Netherlands, Chile, Italy
University Ghent
University Hospital, Ghent

Recruiting

Peripheral Vascular REactivity and Muscular Oxygenation in Diabetes Mellitus (PREMOD)

Diabetes Mellitus | Mitochondrial Diseases | Vascular Complications

Belgium
Fovea Pharmaceuticals SA

Completed

Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy

Diabetic Macular Edema

United States, Australia, Belgium, Czech Republic, France, Germany, Israel, Italy, Poland, Spain
Eli Lilly and Company

Completed

Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes

Type 2 Diabetes

India, Mexico, New Zealand, South Africa
Xequel Bio, Inc.

Terminated

A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer

Diabetic Foot Ulcers

United States, Canada, Hungary, India, Poland
Imcyse SA

Completed

Study of IMCY-0098 in Patients With Recent Onset Type 1 Diabetes

Type 1 Diabetes Mellitus

United Kingdom, Belgium, Denmark, Germany, Lithuania, Sweden, France
University Ghent

Completed

Quality of Life in Patients With Chronic Disease (QAPICHE)

Cardiovascular Diseases | Quality of Life | Diabetes | Chronic Disease | Musculoskeletal Disease | Mental Disorder

Belgium
HealOr
Cato Research; Clinigene International Ltd

Unknown

Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers (Truheal)

Diabetic Foot Ulcer

United States, India
Fractyl Health Inc.

Completed

Effect of Duodenal Mucosal Resurfacing (DMR) Using the Revita System in the Treatment of Type 2 Diabetes (T2D)

Diabetes Mellitus, Type 2 | Noninsulin-Dependent Diabetes Mellitus

United Kingdom, Belgium, Brazil, Italy, Netherlands
Dompé Farmaceutici S.p.A

Terminated

A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.

New-onset Type 1 Diabetes

United States, Belgium, Georgia, Germany, Italy, Serbia
Hasselt University
Jessa Hospital

Completed

Endocrine Regulation of Lipolysis in Obesity and Diabetes (ERLO)

Obesity | Diabetes

Netherlands, Belgium
University Hospital, Ghent

Completed

Erectile Dysfunction and Diabetes Mellitus

Diabetes Mellitus | Erectile Dysfunction

Belgium
Pfizer

Completed

Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (FEENICS)

Diabetic Foot Ulcer

Canada, Greece, Austria, Finland, Poland, Sweden, Russian Federation, Norway, Spain, Italy, United Kingdom, Denmark, Lithuania, Belgium, Germany, Ukraine, Czechia
Universitaire Ziekenhuizen KU Leuven

Recruiting

The Impact of Hybrid Closed-loop Insulin Delivery in Type 1 Diabetes on Glycemic Control and PROMs (INRANGE)

Diabetes Mellitus, Type 1

Belgium
Helmholtz Zentrum München
Universitaire Ziekenhuizen KU Leuven; Technical University of Munich; Medical... and other collaborators

Recruiting

Supplementation With B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity (SINT1A)

Diabetes Mellitus, Type 1

Belgium, Germany, Poland, Sweden, United Kingdom
Bayer

Completed

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease (FIGARO-DKD)

Diabetic Kidney Disease

Belgium, Finland, France, Spain, China, Hong Kong, Switzerland, United States, Colombia, Turkey, Greece, New Zealand, Poland, Korea, Republic of, Portugal, Taiwan, Japan, Russian Federation, Singapore, Australia, Netherlands, Sweden, Austr... and more
Insulet Corporation

Active, not recruiting

Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults (RADIANT)

Diabetes Mellitus, Type 1

Belgium, France, United Kingdom
Novartis Pharmaceuticals

Active, not recruiting

Study of Safety and Efficacy of CFZ533 in Type 1 Diabetes Pediatric and Young Adult Subjects (CCFZ533X2207)

Type 1 Diabetes Mellitus

Belgium, Italy, Spain, United Kingdom, Germany, Slovenia
Sanofi

Completed

Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment

Type 2 Diabetes Mellitus

France, Poland, Germany, Italy, Netherlands, Belgium, Denmark, Chile, South Africa, Australia, Argentina

Clinical Trials on Diabetes, Gestational in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations